72 related articles for article (PubMed ID: 1376840)
1. Postexercise reflex control of forearm vascular resistance during calcium antagonism with slow-release oral isradipine.
Cléroux J; Kouamé N; Yardley C; Marshall A; Lacourcière Y
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S66-9. PubMed ID: 1376840
[TBL] [Abstract][Full Text] [Related]
2. Slow-release isradipine in mild to moderate hypertension: hemodynamic and antihypertensive effects.
Celentano A; Galderisi M; Tammaro P; Mureddu GF; Garofalo M; de Simone G; de Divitiis O
Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):494-8. PubMed ID: 1839903
[TBL] [Abstract][Full Text] [Related]
3. Long-term antihypertensive and renal effects of isradipine in hypertensive patients with normal and reduced renal function.
Wittenberg C; Rosenfeld JB
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S93-5. PubMed ID: 1376848
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the antihypertensive efficacy of isradipine SRO as assessed by ambulatory blood pressure determination].
Waeber B; Soret P; Poget PN; Brunner HR
Schweiz Rundsch Med Prax; 1992 Dec; 81(50):1514-7. PubMed ID: 1465521
[TBL] [Abstract][Full Text] [Related]
5. Isradipine in the treatment of hypertensive crisis in ambulatory patients.
Saragoça MA; Portela JE; Plavnik F; Ventura RP; Lotaif L; Ramos OL
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S76-8. PubMed ID: 1376843
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term administration of isradipine on renal hemodynamics and sodium metabolism.
Francischetti EA; Barroso I; da Silva A; Fagundes VG
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S90-2. PubMed ID: 1376847
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological effects of oral isradipine (Lomir, Sandoz).
Mádle A; Vainer J; Cepelák V; Brunát J; Smíd J
Cor Vasa; 1991; 33(1):35-41. PubMed ID: 1833127
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive and hemodynamic effects of calcium channel blockade with isradipine after acute exercise.
Cléroux J; Yardley C; Marshall A; Coulombe D; Lacourcière Y
Am J Hypertens; 1992 Feb; 5(2):84-7. PubMed ID: 1532316
[TBL] [Abstract][Full Text] [Related]
9. A randomized comparison of isradipine slow release given once daily with isradipine twice daily on 24 hour blood pressure in hypertensive patients.
Christensen HR; Kampmann JP; Simonsen K
J Hum Hypertens; 1991 Apr; 5(2):121-7. PubMed ID: 1830108
[TBL] [Abstract][Full Text] [Related]
10. Does isradipine exert a special early-morning blood pressure-lowering effect?
Viskoper JR; Laszt A; Faraggi D; Yaskil E
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S74-5. PubMed ID: 1376842
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of isradipine and nifedipine in chronic sustained hypertension.
Gross P; Koppenhagen K; Wudel E; Burger KJ; Welzel D; Distler GA
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S84-6. PubMed ID: 1376845
[TBL] [Abstract][Full Text] [Related]
12. [Circadian antihypertensive action and tolerability of a sustained-release form of isradipine in an intra-individual comparison with nitrendipine].
Lohmann FW; Welzel D; Burger KJ
Arzneimittelforschung; 1993 May; 43(5):522-5. PubMed ID: 8328996
[TBL] [Abstract][Full Text] [Related]
13. Regression of cardiac hypertrophy in hypertensive patients by long-term treatment with isradipine.
Török E; Borbás S; Lengyel M; Zorándi A
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S79-83. PubMed ID: 1376844
[TBL] [Abstract][Full Text] [Related]
14. [Circadian antihypertensive effect of sustained-release isradipine in patients with essential hypertension in comparison to placebo].
Burger KJ; Anlauf M
Arzneimittelforschung; 1993 Sep; 43(9):958-62. PubMed ID: 8240458
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological modulation of stress-induced cardiovascular hyperreactivity in essential hypertension.
Schulte W; Rüddel H; Schmieder R; Schächinger H; Bräutigam M; Welzel D
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S70-3. PubMed ID: 1376841
[TBL] [Abstract][Full Text] [Related]
16. Effect of isradipine on responses to standardized physical stress tests in hypertension of pregnancy.
Lunell NO; Grunewald C; Nisell H
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S99-101. PubMed ID: 1376850
[TBL] [Abstract][Full Text] [Related]
17. Effects of sustained-release isradipine on blood pressure and peripheral hemodynamics in hypertensive patients.
Arosio E; Pancera P; Priante F; Ribul M; De Marchi S; Lechi A
Clin Ther; 1993; 15(4):705-13. PubMed ID: 8221821
[TBL] [Abstract][Full Text] [Related]
18. Does antihypertensive therapy affect the natural protection against thrombosis?
Gleerup G; Hedner T; Hjørting Hansen E; Winther K
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S34-6. PubMed ID: 1720483
[TBL] [Abstract][Full Text] [Related]
19. Effect of a new calcium antagonist on hemodynamics at rest and exercise loading in patients with essential hypertension.
Suzuki S; Hashimoto T; Kusano S; Kapuku K; Utsunomiya T; Yano K
Arzneimittelforschung; 1993 Nov; 43(11):1152-6. PubMed ID: 8292057
[TBL] [Abstract][Full Text] [Related]
20. Effect of isradipine on cardiopulmonary baroreflex function, regional blood flow, and vascular responsiveness in hypertensive patients.
Hirsch AT; Dzau VJ; Cutler SS; Levenson DJ; Creager MA
J Cardiovasc Pharmacol; 1992 Feb; 19(2):272-81. PubMed ID: 1376797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
